Table 3.
Primary Drug Resistance Mutations among Newly HIV Diagnosed Individuals, Argentina, 2006–2008a
Group | ID | Subtype | PIs | NRTIs | NNRTIs |
---|---|---|---|---|---|
MSM | M1 | B | L90M | ||
M2 | BF | M46I I54V L76V V82S | K103N | ||
M3 | B | M41L | |||
M4 | B | M41L T215E | |||
M5 | C | D67N T215S K219E | |||
M6 | B | M184V T215Y | K103N | ||
M7&8 | B | G190A | |||
M9&10 | B | K103N | |||
Dus | D1 | B | M46I | ||
D2 | B | V82A | M41L D67N K70R M184V T215Y K219E | K103N | |
D3 | B | M184V | G190A | ||
SWs | S1 | BF | L90M | ||
S2 | BF | V82A | M184V T215Y | K103N P225H | |
S3 | BF | M184V | K103N | ||
S4 | B | K103N | |||
S5 | BF | I54V V82A L90M | M41L L74V M184V T215Y | K101E Y181C G190A |
PIs, protease inhibitors; NRTIs, nucleoside reverse transcriptase inhibitors; NNRTIs, nonnucleoside reverse transcriptase inhibitors; MSM, men who have sex with men; SWs, sex workers; DUs, drug users; HIV, human immunodeficiency virus.